Last reviewed · How we verify
NCT06741267
The Assessment of the Feasibility and Operational Performance of Automated System Bronchoscopy in a Simulated Environment
NA trial testing RBS in Compare Operational Performance of Three Technology in Lung Models in 30 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Guangzhou Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 30 |
| Start date | 1 January 2024 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Chad |
Drugs / interventions tested
- RBS
- AB — full drug profile →
- ENB
Conditions studied
- Compare Operational Performance of Three Technology in Lung Models — all drugs for Compare Operational Performance of Three Technology in Lung Models →
Sponsor
Guangzhou Medical University
Who can join
Eligibility, any sex, with Compare Operational Performance of Three Technology in Lung Models. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recruit 30 trainee physicians from 6 centers and compare their performance in operating lung models using automatic bronchoscopy, robotic bronchoscopy, and electromagnetic navigation bronchoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06741267
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of RBS
Trials testing the same drug.
- NCT05500300 — Electrical Stimulation With Different Currents and Electromagnetic Fields · NA · unknown
- NCT03340337 — Electrical Stimulation With Different Currents: the Effects on Force, Tolerance and Fatigue in Healthy Subjects · NA · completed
Other Guangzhou Medical University trials
Trials by the same sponsor.
- NCT07521618 — One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation · NA · not yet recruiting
- NCT07352176 — Study on the Effectiveness and Safety of CLE Combined With Cryobiopsy for Diagnosis of Pulmonary Lesions · NA · not yet recruiting
- NCT06462092 — Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Canc · Phase 1, PHASE2 · recruiting
- NCT07461714 — AI-Driven Accurate Diagnosis of Pathogens in Severe Pneumonia · active not recruiting
- NCT06296745 — Intrathecal Pemetrexed for Leptomeningeal Metastasis From Lung Adenocarcinoma That Progressed After Osimertinib. · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06741267 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Medical University
- Last refreshed: 18 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06741267.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing